DIMENSIONAL FUND ADVISORS LP - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 46 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$945,000
+1.8%
466,5730.0%0.00%0.0%
Q2 2014$928,000
-36.0%
466,573
-0.9%
0.00%0.0%
Q1 2014$1,450,000
-8.3%
470,6830.0%0.00%0.0%
Q4 2013$1,581,000
+4.7%
470,683
-0.9%
0.00%0.0%
Q3 2013$1,510,000
+5.0%
474,783
-0.3%
0.00%0.0%
Q2 2013$1,438,000476,1390.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,255,691$7,173,0005.84%
NEA Management Company, LLC 2,086,755$6,636,0000.26%
TOURADJI CAPITAL MANAGEMENT, LP 10,000$32,0000.10%
Loeb Offshore Management LP 101,000$321,0000.10%
BVF INC/IL 150,000$477,0000.08%
ABNER HERRMAN & BROCK LLC 20,000$64,0000.04%
SABBY MANAGEMENT, LLC 173,500$552,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 67,000$213,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 52,000$165,0000.00%
PANAGORA ASSET MANAGEMENT INC 96,858$307,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders